BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
批准号:
6931638
负责人:
PHILLIP B HYLEMON
金额:
$26.1万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-21 至 2007-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. Bile acids may help to coordinately regulate cholesterol and phospholipid metabolism in the hepatocyte by modulating the expression of genes encoding bile acid biosyntheticenzymes and phospholipid transport proteins. The mechanisms by which bile acids coordinate the expression of these genes in order to maintain cholesterol homeostasis and the secretion of a specific ratio of cholesterol:bile acids:phospholipids into bile is unclear, but may have important implications in the pathogenesis of cholesterol gallstone formation, hypercholesterolemia, and cholestatic liver diseases. The objectives of the present grant applicationare: (1) To identify bile acid-activated signaling cascades within the hepatocyte and determine if the activation occurs via a protein kinase C-dependent or independent pathway; (2) To determine if bile acids activate receptor protein tyrosine kinases (RPTK) in primary hepatocytes and the bile acid structural requirements for activation; (3) To determine which bile acid-activated down-stream signaling cascade(s) regulate genes involved in maintaining cholesterol and phospholipid homeostasis in the hepatocyte, including: CYP7al, CYPSbl, LDL receptor, neutral cholesterol ester hydrolase (CEH) and mdr2 phospholipid transporter; (4) To determine if the regulation of CYP7al by bile acids and cholesterol metabolism is altered in JNK-1 and JNK-2 knock-out mice and if over-expression of a dominant negative JNK-1 or c-Jun alters CYP7al regulation by bile acids in bile acid fed rats and in a chronic bile fistula rat model. Efforts will be made to determine if bile acids activated signaling pathways "cross-talk" with nuclear receptors i.e. farnesoid X receptor that are also activated by bile acids. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sphingolipids in alcoholic liver disease
-
批准号:10608594
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2023
-
负责人:PHILLIP B HYLEMON
-
依托单位:
LncRNA H19 in Cholestatic Liver Diseases
-
批准号:10202570
-
项目类别:
-
资助金额:$53.65万
-
财政年份:2018
-
负责人:PHILLIP B HYLEMON
-
依托单位:
LncRNA H19 in Cholestatic Liver Diseases
-
批准号:10909545
-
项目类别:
-
资助金额:$62.96万
-
财政年份:2018
-
负责人:PHILLIP B HYLEMON
-
依托单位:
LncRNA H19 in Cholestatic Liver Diseases
-
批准号:9750721
-
项目类别:
-
资助金额:$53.65万
-
财政年份:2018
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis
-
批准号:9024718
-
项目类别:
-
资助金额:$41.17万
-
财政年份:2015
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Role of Bile Acids and Gut Bacteria in GI Diseases
-
批准号:8698288
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Role of Bile Acids and Gut Bacteria in GI Diseases
-
批准号:8536579
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Bile Acids and Clostridium scindens Inhibit C. difficile: Role of Secreted Antibacterial Compounds
-
批准号:9233344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Role of Bile Acids and Gut Bacteria in GI Diseases
-
批准号:8324091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:7035831
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:6799002
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:6861103
-
项目类别:
-
资助金额:$33.23万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:7189897
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
-
批准号:7371133
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2004
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6369833
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6524254
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid Metabolism
-
批准号:8824513
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6787328
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
Bile Acid Activated Cell Signaling in the Liver and Nutrition
-
批准号:7629638
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
BILE ACID SIGNALING & HEPATIC CHOLESTEROL METABOLISM
-
批准号:6661859
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2001
-
负责人:PHILLIP B HYLEMON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
棕榈酸Palmitic acid通过靶向JAK-STAT通路促进致病性Th17细胞分化在儿童性系统性红斑狼疮中的作用及机制研究
-
批准号:2026JJ81716
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐金玲
-
依托单位:
基于F/IGF1R/PKC ζ 通路研究夏枯草中
Mesonolic acid B抑制RSV感染性肺炎的
作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:唐维
-
依托单位:
Quinic acid通过抑制肠道菌群代谢产物脱氧胆酸调节巨噬细胞M1向M2极化改善动脉粥样硬化的机制研究
-
批准号:2025JJ80556
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吴鹏翠
-
依托单位:
巨噬细胞来源代谢物suberic acid抑制蜕膜早衰防治早产的作用机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:梅又文
-
依托单位:
色氨酸代谢产物Kynurenic Acid在脓毒症肠损伤中的诊断价值及其机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:5.0万元
-
批准年份:2024
-
负责人:陈慧
-
依托单位:
石榴皮活性成分Ellagic acid调控脂肪酸代谢重编程抑制NASH相关肝癌发生的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
具有抗耐药甲氧西林金黄色葡萄球菌活性天然产物quiannulatic acid的分子作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2022
-
负责人:韩晓乐
-
依托单位:
丹参红花药对活性组分 Salvianolic acid B-Hydrosafflow yellow A 调控Piezo1-YAP/TAZ-JNK 调节动脉粥样硬化炎症反应机制的研究
-
批准号:LQ22H290004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:张春晓
-
依托单位:
DPA(docosapentaenoic acid, 22:5n-3)对溃疡性结肠炎小鼠肠道菌群影响及特异性菌群筛选的研究
-
批准号:LQ22C200008
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:郑振霄
-
依托单位:
木霉菌抗真菌物质Harzianic Acid的合成机制及其应用研究
-
批准号:32072674
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张建
-
依托单位: